Holen Sie sich die Stockscreener-App
82.56
5.13%
-4.46
Handel nachbörslich:
82.56
Schlusskurs vom Vortag:
$87.02
Offen:
$87
24-Stunden-Volumen:
703.39K
Relative Volume:
0.78
Marktkapitalisierung:
$4.73B
Einnahmen:
$360.35M
Nettoeinkommen (Verlust:
$-149.57M
KGV:
-27.89
EPS:
-2.96
Netto-Cashflow:
$-81.27M
1W Leistung:
-5.55%
1M Leistung:
-5.67%
6M Leistung:
-7.92%
1J Leistung:
-35.62%
1-Tages-Spanne:
$82.37
$87.00
1-Wochen-Bereich:
$82.37
$89.29
52-Wochen-Spanne:
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Firmenname
Glaukos Corporation
Sektor
Branche
Telefon
949-367-9600
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Vergleichen Sie GKOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
82.56 | 4.99B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | Goldman | Buy |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Eingeleitet | Truist | Buy |
| 2023-11-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-04 | Eingeleitet | Needham | Buy |
| 2022-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-11-03 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Eingeleitet | Jefferies | Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Sell |
| 2020-02-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Hochstufung | Berenberg | Hold → Buy |
| 2019-12-12 | Herabstufung | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Eingeleitet | BTIG Research | Neutral |
| 2018-08-30 | Eingeleitet | Berenberg | Hold |
| 2018-08-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Bestätigt | Stifel | Hold |
| 2018-06-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | Cantor Fitzgerald | Buy |
| 2017-03-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2016-10-27 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
How to build a custom watchlist for Glaukos CorporationJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Glaukos Corporation stock trend outlook and recovery pathQuarterly Trade Review & Reliable Entry Point Alerts - newser.com
Using Python tools to backtest Glaukos Corporation strategiesQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Will Glaukos Corporation stock outperform energy sector in 20252025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com
How hedge fund analytics apply to Glaukos Corporation stockPrice Action & Advanced Swing Trade Entry Plans - newser.com
Glaukos Corporation (NYSE:GKOS) Shares Could Be 46% Below Their Intrinsic Value Estimate - 富途牛牛
Analyzing net buyer seller activity in Glaukos Corporation2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Will Glaukos Corporation stock attract long term capital inflows - newser.com
Glaukos' (GKOS) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
How to read the order book for Glaukos Corporation2025 Short Interest & Fast Gaining Stock Reports - newser.com
Glaukos gains as Goldman Sachs initiates at Buy on valuation - MSN
Stifel maintains Buy rating on Glaukos stock ahead of Epioxa PDUFA date - Investing.com Nigeria
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29 - The Globe and Mail
Glaukos Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Citigroup Issues Pessimistic Forecast for Glaukos (NYSE:GKOS) Stock Price - MarketBeat
GKOS: Citigroup Lowers Price Target, Maintains Buy Rating | GKOS Stock News - GuruFocus
Glaukos breaks ground on high-tech facility in Huntsville, eyes 150 jobs - Alabama Department of Commerce
Volume spikes in Glaukos Corporation stock – what they meanQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - newser.com
Is Glaukos Corporation stock bottoming outJuly 2025 Analyst Calls & Short-Term High Return Ideas - newser.com
Glaukos (GKOS): Valuation Spotlight as Goldman Sachs Highlights Pharma Growth Pivot and Innovative Pipeline - simplywall.st
Will Glaukos Corporation benefit from macro trends2025 Support & Resistance & High Yield Stock Recommendations - newser.com
Quantitative breakdown of Glaukos Corporation recent moveMarket Activity Recap & Real-Time Volume Analysis - newser.com
Detecting support and resistance levels for Glaukos CorporationJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Published on: 2025-10-05 05:39:03 - newser.com
Will Glaukos Corporation stock maintain growth story2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Why Glaukos Corporation (6GJ) stock is trending on social mediaQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com
What macro factors could drive Glaukos Corporation (6GJ) stock higherEarnings Miss & Daily Profit Focused Stock Screening - newser.com
Using Bollinger Bands to evaluate Glaukos CorporationQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Is Glaukos Corporation stock a fit for income portfoliosJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Glaukos (NYSE:GKOS) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Is Glaukos Corporation (6GJ) stock positioned for digital growth eraJuly 2025 Sentiment & Weekly Market Pulse Alerts - newser.com
What makes Glaukos Corporation stock attractive to growth fundsJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com
Published on: 2025-10-03 05:01:41 - newser.com
How Glaukos’ (GKOS) New Huntsville Facility Expansion Has Changed Its Investment Story - simplywall.st
Building trade automation scripts for Glaukos CorporationCEO Change & Accurate Intraday Trade Tips - newser.com
How cyclical is Glaukos Corporation (6GJ) stock compared to rivalsGlobal Markets & Stepwise Trade Execution Plans - newser.com
Can Glaukos Corporation stock withstand sector downturnsInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-03 02:27:59 - newser.com
Risk adjusted return profile for Glaukos Corporation analyzedGap Up & High Accuracy Investment Entry Signals - newser.com
Finanzdaten der Glaukos Corporation-Aktie (GKOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):